Juliet Williams

4.2k total citations
14 papers, 707 citations indexed

About

Juliet Williams is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Juliet Williams has authored 14 papers receiving a total of 707 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Juliet Williams's work include Cancer-related Molecular Pathways (5 papers), Hedgehog Signaling Pathway Studies (3 papers) and CAR-T cell therapy research (3 papers). Juliet Williams is often cited by papers focused on Cancer-related Molecular Pathways (5 papers), Hedgehog Signaling Pathway Studies (3 papers) and CAR-T cell therapy research (3 papers). Juliet Williams collaborates with scholars based in United States, Switzerland and China. Juliet Williams's co-authors include Lee L. Rubin, Yin Xu, Hynek Wichterle, Jeffery A. Porter, Frank Y. Wang, Oivin Guicherit, Ling Chai, Christine L. Gatchalian, Hui Gao and Brandon Nicolay and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Cancer Research.

In The Last Decade

Juliet Williams

14 papers receiving 692 citations

Peers

Juliet Williams

ONCOL

PRM

GENET

Silvia Pietrobono Italy

Shengyan Xiang United States

Maria J. Sambade United States

Rosanna Lacalamita Italy

Abdelkader Selmi France

Isere Kuiatse United States

Sara Volorio Italy

Roza Zandi Denmark

Roderick P. Regala United States

Mark Miglarese United States

Silvia Pietrobono Italy

Juliet Williams

710 ×1.5

294 ×1.1

ONCOL

133 ×1.0

67 ×0.6

PRM

90 ×1.1

GENET

Citations per year, relative to Juliet Williams Juliet Williams (= 1×) peers Silvia Pietrobono

Countries citing papers authored by Juliet Williams

Since Specialization

Citations

This map shows the geographic impact of Juliet Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juliet Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juliet Williams more than expected).

Fields of papers citing papers by Juliet Williams

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juliet Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juliet Williams. The network helps show where Juliet Williams may publish in the future.

Co-authorship network of co-authors of Juliet Williams

This figure shows the co-authorship network connecting the top 25 collaborators of Juliet Williams. A scholar is included among the top collaborators of Juliet Williams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juliet Williams. Juliet Williams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Collier, Philip N., Matthew M. Weiss, Dapeng Chen, et al.. (2025). Discovery of Selective and Orally Bioavailable Heterobifunctional Degraders of Cyclin-Dependent Kinase 2. Journal of Medicinal Chemistry. 68(17). 18407–18422. 1 indexed citations

Wang, Hui Qin, Iain J. Mulford, Fiona A. Sharp, et al.. (2021). Inhibition of MDM2 Promotes Antitumor Responses in p53 Wild-Type Cancer Cells through Their Interaction with the Immune and Stromal Microenvironment. Cancer Research. 81(11). 3079–3091. 43 indexed citations

Feng, Tianshu, Javad Golji, Ailing Li, et al.. (2019). Distinct Transcriptional Programming Drive Response to MAPK Inhibition in BRAF V600-Mutant Melanoma Patient-Derived Xenografts. Molecular Cancer Therapeutics. 18(12). 2421–2432. 2 indexed citations

Wang, Hui Qin, Jinsheng Liang, Iain J. Mulford, et al.. (2018). Abstract 5560: PD-1/PD-L1 blockade enhances MDM2 inhibitor activity in p53 wild-type cancers. Cancer Research. 78(13_Supplement). 5560–5560. 3 indexed citations

Williams, Juliet. (2018). Using PDX for Preclinical Cancer Drug Discovery: The Evolving Field. Journal of Clinical Medicine. 7(3). 41–41. 61 indexed citations

Wang, Haizhen, Brandon Nicolay, Joel M. Chick, et al.. (2017). The metabolic function of cyclin D3–CDK6 kinase in cancer cell survival. Nature. 546(7658). 426–430. 263 indexed citations

Collins, Scott D., Carl Uli Bialucha, Juliet Williams, & Hui Gao. (2017). Utilizing panels of patient derived xenografts to aid the development of antibody drug conjugates. Molecular & Cellular Oncology. 5(1). e1394422–e1394422. 1 indexed citations

Wang, Hui Qin, Ensar Halilovic, Xiaoyan Li, et al.. (2017). Combined ALK and MDM2 inhibition increases antitumor activity and overcomes resistance in human ALK mutant neuroblastoma cell lines and xenograft models. eLife. 6. 34 indexed citations

Gao, Hui & Juliet Williams. (2016). Predicting human clinical trial responses in mice. Molecular & Cellular Oncology. 5(2). e1162895–e1162895. 3 indexed citations

10.

Greco, Rita, Fangxian Sun, Qunyan Yu, et al.. (2012). Abstract 1796: SAR302503: A Jak2 inhibitor with antitumor activity in solid tumor models. Cancer Research. 72(8_Supplement). 1796–1796. 4 indexed citations

11.

Blackburn, Christopher, Matthew O. Duffey, Alexandra E. Gould, et al.. (2010). Discovery and optimization of N-acyl and N-aroylpyrazolines as B-Raf kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(16). 4795–4799. 35 indexed citations

12.

Buonamici, Silvia, Beatriz Muñoz, Jing Yuan, et al.. (2010). Abstract 4290: The smoothened antagonist NVP-LDE225 targets stroma and cancer stem cells in primary human pancreatic tumor xenografts. Cancer Research. 70(8_Supplement). 4290–4290. 4 indexed citations

13.

Williams, Juliet. (2005). Hedgehog and spinal cord injury. Expert Opinion on Therapeutic Targets. 9(6). 1137–1145. 5 indexed citations

14.

Williams, Juliet, Oivin Guicherit, Yin Xu, et al.. (2003). Identification of a small molecule inhibitor of the hedgehog signaling pathway: Effects on basal cell carcinoma-like lesions. Proceedings of the National Academy of Sciences. 100(8). 4616–4621. 248 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact